Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Insights into Imaging
Published in: Insights into Imaging 5/2018

Open Access 01-10-2018 | Pictorial Review

Differential diagnosis of thickened myocardium: an illustrative MRI review

Authors: Cristina Méndez, Rafaela Soler, Esther Rodríguez, Roberto Barriales, Juan Pablo Ochoa, Lorenzo Monserrat

Published in: Insights into Imaging | Issue 5/2018

Login to get access

Abstract

Objectives

The purpose of this article is to describe the key cardiac magnetic resonance imaging (MRI) features to differentiate hypertrophic cardiomyopathy (HCM) phenotypes from other causes of myocardial thickening that may mimic them.

Conclusions

Many causes of myocardial thickening may mimic different HCM phenotypes. The unique ability of cardiac MRI to facilitate tissue characterisation may help to establish the aetiology of myocardial thickening, which is essential to differentiate it from HCM phenotypes and for appropriate management.

Teaching points

• Many causes of myocardial thickening may mimic different HCM phenotypes.
• Differential diagnosis between myocardial thickening aetiology and HCM phenotypes may be challenging.
• Cardiac MRI is essential to differentiate the aetiology of myocardial thickening from HCM phenotypes.
Literature
1.
Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary Artery Risk Development in (Young) Adults. Circulation 92:785–789CrossRef
2.
Maceira AM, Mohiaddin RH (2012) Cardiovascular magnetic resonance in systemic hypertension. J Cardiovasc Magn Reson 14:28CrossRef
3.
Sankaranarayanan R, J Fleming E, J Garratt C (2013) Mimics of hypertrophic cardiomyopathy—diagnostic clues to aid early identification of phenocopies. Arrhythm Electrophysiol Rev 2:36–40CrossRef
4.
Bogaert J, Olivotto I (2014) MR imaging in hypertrophic cardiomyopathy: from magnet to bedside. Radiology 273:329–348CrossRef
5.
Fulton N, Rajiah P (2017) Utility of magnetic resonance imaging in the evaluation of left ventricular thickening. Insights Imaging 8:279–293CrossRef
6.
American College of Cardiology Foundation/American Heart Association Task Force on Practice, American Association for Thoracic Surgery, American Society of Echocardiography et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg 142:e153–e203
7.
Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA et al (2014) ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology. Eur Heart J 35:2733–2779CrossRef
8.
Baxi AJ, Restrepo CS, Vargas D, Marmol-Velez A, Ocazionez D, Murillo H (2016) Hypertrophic cardiomyopathy from A to Z: genetics, pathophysiology, imaging, and management. Radiographics 36:335–354CrossRef
9.
Choudhury L, Rigolin VH, Bonow RO (2017) Integrated imaging in hypertrophic cardiomyopathy. Am J Cardiol 119:328–339CrossRef
10.
Pelliccia A, Caselli S, Sharma S et al (2018) European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement: recommendations for the indication and interpretation of cardiovascular imaging in the evaluation of the athlete’s heart. Eur Heart J 39:1949–1969CrossRef
11.
Petersen SE, Selvanayagam JB, Francis JM et al (2005) Differentiation of athlete’s heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 7:551–558CrossRef
12.
Maron BJ, Pelliccia A, Spirito P (1995) Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete’s heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 91:1596–1601CrossRef
13.
Makan J, Sharma S, Firoozi S, Whyte G, Jackson PG, McKenna WJ (2005) Physiological upper limits of ventricular cavity size in highly trained adolescent athletes. Heart 91:495–499CrossRef
14.
Luijkx T, Cramer MJ, Buckens CF et al (2015) Unravelling the grey zone: cardiac MRI volume to wall mass ratio to differentiate hypertrophic cardiomyopathy and the athlete’s heart. Br J Sports Med 49:1404–1409CrossRef
15.
Vinereanu D, Florescu N, Sculthorpe N, Tweddel AC, Stephens MR, Fraser AG (2001) Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol 88:53–58CrossRef
16.
Breuckmann F, Möhlenkamp S, Nassenstein K et al (2009) Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology 25:50–57CrossRef
17.
Van de Schoor FR, Aengevaeren VL, Hopman MT et al (2016) Myocardial fibrosis in athletes. Mayo Clin Proc 91:1617–1631CrossRef
18.
Pelliccia A, Maron MS, Maron BJ (2012) Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete’s heart from pathologic hypertrophy. Prog Cardiovasc Dis 54:387–396CrossRef
19.
Swoboda PP, McDiarmid AK, Erhayiem B et al (2016) Assessing myocardial extracellular volume by T1 mapping to distinguish hypertrophic cardiomyopathy from athlete’s heart. J Am Coll Cardiol 67:2189–2190CrossRef
20.
Drazner MH (2011) The progression of hypertensive heart disease. Circulation 123:327–334CrossRef
21.
Mavrogeni S, Katsi V, Vartela V et al (2017) The emerging role of cardiovascular magnetic resonance in the evaluation of hypertensive heart disease. BMC Cardiovasc Disord 17:132CrossRef
22.
Rodrigues JC, Rohan S, Dastidar AG et al (2016) The relationship between left ventricular wall thickness, myocardial shortening, and ejection fraction in hypertensive heart disease: insights from cardiac magnetic resonance imaging. J Clin Hypertens (Greenwich) 18:1119–1127CrossRef
23.
Rodrigues JC, Rohan S, Ghosh Dastidar A et al (2017) Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15mm. Eur Radiol 27:1125–1135CrossRef
24.
Wachtell K, Smith G, Gerdts E et al (2000) Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan intervention for endpoint. Am J Cardiol 85:466–472CrossRef
25.
Wang S, Hu H, Lu M et al (2017) Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling. Eur Radiol 27:4620–4630CrossRef
26.
Rodrigues JC, Amadu AM, Dastidar AG et al (2016) Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes. Heart 102:1671–1679CrossRef
27.
Hein S, Arnon E, Kostin S et al (2003) Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107:984–991CrossRef
28.
Dweck MR, Joshi S, Murigu T et al (2012) Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 14:50CrossRef
29.
Barone-Rochette G, Piérard S, De Meester de Ravenstein C et al (2014) Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. J Am Coll Cardiol 64:144–1454CrossRef
30.
Amano Y, Takayama M, Kumita S (2009) Cardiac magnetic resonance imaging findings are useful for differentiating between hypertrophic obstructive cardiomyopathy and aortic valve stenosis in elderly patients. J Comput Assist Tomogr 33:354–358CrossRef
31.
Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C (2017) Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation 135:1357–1377CrossRef
32.
Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ (2008) Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 10:54CrossRef
33.
Syed IS, Glockner JF, Feng D et al (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 3:155–164CrossRef
34.
Dinwoodey DL, Skinner M, Maron MS, Davidoff R, Ruberg FL (2008) Light-chain amyloidosis with echocardiographic features of hypertrophic cardiomyopathy. Am J Cardiol 101:674–676CrossRef
35.
Maceira AM, Joshi J, Prasad SK et al (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111:186–193CrossRef
36.
Banypersad SM, Sado DM, Flett AS et al (2013) Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 6:34–39CrossRef
37.
Fontana M, Pica S, Reant P et al (2015) Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 132:1570–1579CrossRef
38.
Williams LK, Forero JF, Popovic ZB et al (2017) Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics. J Cardiovasc Magn Reson 19:61CrossRef
39.
Jeudy J, Burke AP, White CS, Kramer GB, Frazier AA (2015) Cardiac sarcoidosis: the challenge of radiologic-pathologic correlation: from the radiologic pathology archives. Radiographics 35:657–679CrossRef
40.
Tavora F, Cresswell N, Li L, Ripple M, Solomon C, Burke A (2009) Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 104:571–577CrossRef
41.
Puntmann VO, Isted A, Hinojar R, Foote L, Carr-White G, Nagel E (2017) T1 and T2 mapping in recognition of early cardiac involvement in systemic sarcoidosis. Radiology 285:63–72CrossRef
42.
Murtagh G, Laffin LJ, Beshai JF et al (2016) Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance. Circ Cardiovasc Imaging 9:e003738CrossRef
43.
Matsumori A, Hara M, Nagai S et al (2000) Hypertrophic cardiomyopathy as a manifestation of cardiac sarcoidosis. Jpn Circ J 64:679–683CrossRef
44.
Agarwal A, Sulemanjee NZ, Cheema O, Downey FX, Tajik AJ (2014) Cardiac sarcoid: a chameleon masquerading as hypertrophic cardiomyopathy and dilated cardiomyopathy in the same patient. Echocardiography 3:E138–E141CrossRef
45.
Maron MS, Finley JJ, Bos JM (2008) Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 118:1541–1549CrossRef
46.
Saremi F (2017) Cardiac MR imaging in acute coronary syndrome: application and image interpretation. Radiology 282:17–32CrossRef
47.
Zuccarino F, Vollmer I, Sanchez G, Navallas M, Pugliese F, Gayete A (2015) Left ventricular noncompaction: imaging findings and diagnostic criteria. AJR Am J Roentgenol 204:W519–W530CrossRef
48.
Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA (2001) Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart 86:666–671CrossRef
49.
Ikeda U, Minamisawa M, Koyama J (2015) Isolated left ventricular non-compaction cardiomyopathy in adults. J Cardiol 65:91–97CrossRef
50.
51.
Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R (2000) Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 36:493–500CrossRef
52.
Petersen SE, Selvanayagam JB, Wiesmann F et al (2005) Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 46:101–105CrossRef
53.
Paterick TE, Tajik AJ (2012) Left ventricular noncompaction: a diagnostically challenging cardiomyopathy. Circ J 76:1556–1562CrossRef
54.
Monserrat L, Barriales-Villa R, Hermida-Prieto M (2008) Apical hypertrophic cardiomyopathy and left ventricular non-compaction: two faces of the same disease. Heart 94:1253CrossRef
55.
Stöllberger C, Finsterer J (2004) Left ventricular hypertrabeculation/noncompaction. J Am Soc Echocardiogr 17:91–100CrossRef
56.
Stöllberger C, Finsterer J (2006) Pitfalls in the diagnosis of left ventricular hypertrabeculation/non-compaction. Postgrad Med J 82:679–683CrossRef
57.
Puvaneswary M, Joshua F, Ratnarajah S (2001) Idiopathic hypereosinophilic syndrome: magnetic resonance imaging findings in endomyocardial fibrosis. Australas Radiol 45:524–527CrossRef
58.
Maia CP, Gali LG, Schmidt A et al (2016) A challenging differential diagnosis: distinguishing between endomyocardial fibrosis and apical hypertrophic cardiomyopathy. Echocardiography 33:1080–1084CrossRef
59.
Salanitri GC (2005) Endomyocardial fibrosis and intracardiac thrombus occurring in idiopathic hypereosinophilic syndrome. AJR Am J Roentgenol 184:1432–1433CrossRef
60.
Alter P, Maisch B (2006) Endomyocardial fibrosis in Churg-Strauss syndrome assessed by cardiac magnetic resonance imaging. Int J Cardiol 108:112–113CrossRef
61.
Khanna R, Kapoor A, Soni N (2016) A heart set in stone: a case of extensive cardiac calcification. Heart Views 17:100–102CrossRef
Metadata
Title
Differential diagnosis of thickened myocardium: an illustrative MRI review
Authors
Cristina Méndez
Rafaela Soler
Esther Rodríguez
Roberto Barriales
Juan Pablo Ochoa
Lorenzo Monserrat
Publication date
01-10-2018
Publisher
Springer Berlin Heidelberg
Published in
Insights into Imaging / Issue 5/2018
Electronic ISSN: 1869-4101
DOI
https://doi.org/10.1007/s13244-018-0655-9

Other articles of this Issue 5/2018

Insights into Imaging 5/2018 Go to the issue

Pictorial Review

Xantogranulomatous pyeloneprhritis in children

Pictorial Review

Magnetic resonance imaging of arterial stroke mimics: a pictorial review

Pictorial Review

Imaging in Lyme neuroborreliosis

Pictorial Review

Acute mesenteric ischaemia: a pictorial review

Pictorial Review

Spectrum of lytic lesions of the skull: a pictorial essay

Pictorial Review

Odontogenic keratocyst: imaging features of a benign lesion with an aggressive behaviour